Geospiza Sells Genetics Software To Harvard Medical, Children’s Hospital Boston

Luke Timmerman11/18/08

Geospiza, a Seattle-based maker of software to help researchers analyze reams of genomic data, said today it has sold its FinchLab product to the Molecular Genetics Core Facility shared by Children’s Hospital Boston and Harvard Medical School. Terms of the transaction weren’t disclosed, although Geospiza president Rob Arnold said it June that it typically charges $30,000 for software, or about $2,500 a month.

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @